CN1319515C - Eye-cream for developing eye cytoactive - Google Patents
Eye-cream for developing eye cytoactive Download PDFInfo
- Publication number
- CN1319515C CN1319515C CNB200510046860XA CN200510046860A CN1319515C CN 1319515 C CN1319515 C CN 1319515C CN B200510046860X A CNB200510046860X A CN B200510046860XA CN 200510046860 A CN200510046860 A CN 200510046860A CN 1319515 C CN1319515 C CN 1319515C
- Authority
- CN
- China
- Prior art keywords
- eye
- oil
- eyes
- eye cream
- oxidoreductase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Cosmetics (AREA)
Abstract
The present invention relates to an eye cream for developing the skin around eyes, which is mainly prepared from Jojoba oil, olive oil, synthetic squalane, simethicone, vitamin E oil, shea butter, octadecy l alcohol, octadecanoic acid monoglyceride, hydroxybenzoic acid propyl ester, methyl glucoside sesqni-stearate, methyl gluoside polyethyleneglycol-2 ether semi-stearine, glycerol, carbomer, soybean peptide, oxidoreductase, hydrolytic rice bran protein, GM preservative (imidazolidinyl urea), essence and distilled water. Because the present invention contains the soybean peptides, the oxidoreductase (SOD) and the hydrolytic rice bran proteins, the eye cream can positively promote the blood circulation of eyes, protect basic supporting tissues of collagen, elastin, etc. and clean away surplus free radical ions. In addition, the eye cream can prevent connective tissues of free radicals, etc. from degrading, enhance the vigor performance of cells of eyes, and effectively inhibit and improve the occurrence of dark pouches and pouches of eyes.
Description
Technical field: the present invention relates to a kind of cosmetics, relate to a kind of cosmetics that contain soybean peptide, oxidoreductase, hydrolysis rice bran protein specifically.
Background technology: eye part skin is one of skin histology of the most tender and lovely weakness in the human epidermal, and just because of this, skin herein is the easiest to be aging, thereby exposes people's the true age.Along with the human senescence process, the continuous attenuation of skin is herein followed the string, and wrinkle occurs, and is more prone to be stimulated.Suffering under the stimulation situation of UV light, skin also is the position that the easiest radical ion that is subjected to being caused by UV light injures herein, and may stay permanent vestige, thereby brings burden and shade on psychological aspect.Usually the eye skin aging appearance of eye pouch, black eye and crows-feet that invariably accompanies, and the appearance of these outward appearances is all owing to its intrinsic physiological change causes: blood circulation slows down, oxygen supply not enough and generation, the microcirculation of various stimulation situations slow down, the increase of body internal protein catabolic enzyme burst size/concentration, remove outside the human body self physiological reason, some external factor such as the stimulation of UV light play an important role to skin aging equally.Eye-care product on the market are more now, are some daily preserving moisture and wrinkle removal mostly, and at aspects such as eye wrinkle removal stricture of vagina, the eye pouch of dispelling, the black eye of dispelling, eye cream does not appear in the newspapers targetedly.
Summary of the invention: the present invention is directed to the defective that existing wrinkle removal class cosmetics exist, when being provided, a kind of use has the eye of enhancing cell viability, effectively suppress and improve the cosmetics of eye black eye, eye pouch appearance, for reaching above-mentioned purpose, concrete technical scheme of the present invention is: a kind of reinforcing eye cream is to be formed by oil phase and water constituent intimate mixing: prescription: calculate with 100 mass parts, below each constituent mass part: oil phase: Jojoba oil 3.5-5.0; Olive oil 0.5-1.0; Synthetic squalane 1.0-2.0; Dimethicone 1.0-2.0; Dimension E oil 1.0-1.2; Shea butter 2.0-3.0; Octadecanol 1.5-2.0; Glycerol monostearate 1.4-1.7; Nipasol 0.1-0.2; Methyl glucoside sesqui-stearate 1.0-1.2; Methyl glucoside Polyethylene Glycol-2 ether semi-solid fat acid esters 1.1-1.8; Water: glycerol 2.0-3.0; Card ripple 0.1-0.2; Soybean peptide 1.0-1.5; Oxidoreductase (SOD) 1.0-1.8; Hydrolysis rice bran protein 1.0-1.7; Germall antiseptic (imidazolidinyl urea) 0.2-0.3; Essence 0.1-0.2; Distilled water surplus.
Soybean peptide in the reinforcing eye cream of the present invention, oxide reductase (SOD), hydrolysis rice bran protein have positive promotion ocular blood circulation, can protect base support tissues such as collagen protein and elastin laminin; Can remove unnecessary radical ion; Resist connective tissue degenerations such as free radical, strengthen eye cell viability performance, effectively suppress and improve the appearance of eye black eye, eye pouch.
Detect short APTT prothrombin activating kinases and thrombin local action time by adding the active eye cream of not commensurability the present invention, and compare, judge that it the results are shown in Figure 1 for blood circulation and microcirculatory effect with not adding the active eye cream of the present invention.
By this prescription, launch test for 30 testees respectively.Testee uses after carrying out facial cleansing every day, continues to use for 8 weeks.Experiment shows, eye black eye phenomenon decreased average 35%; Eye pouch phenomenon decreased average 31%; Skin texture on average improves 42%.
Beneficial effect of the present invention: the present invention is owing to contain soybean peptide, oxide reductase (SOD), hydrolysis rice bran protein.This product has positive promotion ocular blood circulation, can protect base support tissues such as collagen protein and elastin laminin; Can remove unnecessary radical ion; Resist connective tissue degenerations such as free radical, strengthen eye cell viability performance, can effectively suppress and improve the appearance of eye black eye, eye pouch.
Description of drawings:
Fig. 1 is that active eye cream consumption is to thrombokinase, thrombin action time comparison diagram.
The specific embodiment:
Embodiment 1:
With the oil phase raw material: Jojoba oil 5.0g, olive oil 1.0g, synthetic squalane 2.0g, dimethicone 2.0g, dimension E oil 1.2g, shea butter 3.0g, octadecanol 2.0g, glycerol monostearate 1.7g, nipasol 0.2g, methyl glucoside sesquialter stearic acid 1.2g, methyl glucoside Polyethylene Glycol-2 ether semi-solid fat acid esters 1.8g weigh up post-heating to 75 ℃ stirring and dissolving successively; With the water raw material: glycerol 3.0g, carbopol 940 0.2g, distilled water 70.2g post-heating to the 75 ℃ stirring and dissolving of weighing, then the water raw material is slowly poured in the oil phase raw material and stirred, when treating that temperature is reduced to 40 ℃, adding soybean peptide 1.5g, oxidoreductase (SOD) 1.8g, hydrolysis rice bran protein 1.7g, germall antiseptic (imidazolidinyl urea) 0.3g stir and transfer pH to 6.5 with triethanolamine, add essence 0.2g, emulsifying discharging in 3 minutes.
The reinforcing eye cream of this formulated is applicable to eliminates eye pouch, black eye, wrinkle.
Embodiment 2:
With the oil phase raw material: Jojoba oil 3.5g, olive oil 0.5g, synthetic squalane 1.0g, dimethicone 1.0g, dimension E oil 1.0g, shea butter 2.0g, octadecanol 1.5g, glycerol monostearate 1.4g, nipasol 0.1g, methyl glucoside sesquialter stearic acid 1.0g, methyl glucoside Polyethylene Glycol-2 ether semi-solid fat acid esters 1.1g weigh up post-heating to 75 ℃ stirring and dissolving successively; With the water raw material: glycerol 2.0g, card ripple 941 0.1g, distilled water 80.4g post-heating to the 75 ℃ stirring and dissolving of weighing, then the water raw material is slowly poured in the oil phase raw material and stirred, when treating that temperature is reduced to 40 ℃, adding soybean peptide 1.0g, oxidoreductase (SOD) 1.0g, hydrolysis rice bran protein 1.0g, germall antiseptic (imidazole ureine) 0.2g stir and transfer pH6.5 with triethanolamine, add essence 0.2g, emulsifying discharging in 3 minutes.
The reinforcing eye cream of this formulated is applicable to and suppresses black eye and wrinkle appearance.
Embodiment 3:
With the oil phase raw material: Jojoba oil 4.0g, olive oil 0.7g, synthetic squalane 1.5g, dimethicone 1.5g, dimension E oil 1.1g, shea butter 2.5g, octadecanol 1.7g, glycerol monostearate 1.6g, nipasol 0.15g, methyl glucoside sesquialter stearic acid 1.1g, methyl glucoside Polyethylene Glycol-2 ether semi-solid fat acid esters 1.5g weigh up post-heating to 75 ℃ stirring and dissolving successively; With the water raw material: glycerol 2.5g, card ripple 941 0.2g, distilled water 75.5g post-heating to the 75 ℃ stirring and dissolving of weighing, then the water raw material is slowly poured in the oil phase raw material and stirred, when treating that temperature is reduced to 40 ℃, adding soybean peptide 1.3g, oxidoreductase (SOD) 1.4g, hydrolysis rice bran protein 1.3g, germall antiseptic (imidazolidinyl urea) 0.25g stir and transfer pH6.5 with triethanolamine, add essence 0.2g, emulsifying discharging in 3 minutes.
The reinforcing eye cream of this formulated is applicable to eliminates black eye and degree of depth wrinkle.
Claims (1)
1, a kind of reinforcing eye cream is characterized in that: prescription: calculate with 100 mass parts, below each constituent mass part: oil phase: Jojoba oil 3.5-5.0; Olive oil 0.5-1.0; Synthetic squalane 1.0-2.0; Dimethicone 1.0-2.0; Dimension E oil 1.0-1.2; Shea butter 2.0-3.0; Octadecanol 1.5-2.0; Glycerol monostearate 1.4-1.7; Nipasol 0.1-0.2; Methyl glucoside sesqui-stearate 1.0-1.2; Methyl glucoside Polyethylene Glycol-2 ether semi-solid fat acid esters 1.1-1.8; Water: glycerol 2.0-3.0; Carbopol 940 0.1-0.2; Soybean peptide 1.0-1.5; Oxidoreductase 1.0-1.8; Hydrolysis rice bran protein 1.0-1.7; Germall antiseptic imidazolidinyl urea 0.2-0.3; Essence 0.1-0.2; Distilled water surplus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510046860XA CN1319515C (en) | 2005-07-12 | 2005-07-12 | Eye-cream for developing eye cytoactive |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510046860XA CN1319515C (en) | 2005-07-12 | 2005-07-12 | Eye-cream for developing eye cytoactive |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1723876A CN1723876A (en) | 2006-01-25 |
| CN1319515C true CN1319515C (en) | 2007-06-06 |
Family
ID=35923592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200510046860XA Active CN1319515C (en) | 2005-07-12 | 2005-07-12 | Eye-cream for developing eye cytoactive |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1319515C (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101732172B (en) * | 2009-12-03 | 2011-12-14 | 浙江传化江南大地发展有限公司 | Superoxide dismutase-containing toner and preparation method thereof |
| CN103622879B (en) * | 2013-12-12 | 2015-10-21 | 顾祥茂 | A kind of day cream containing Peanut Polypeptide and preparation method thereof |
| CN103610617B (en) * | 2013-12-12 | 2015-06-10 | 孙晓晨 | Day cream containing soybean peptide and preparation method of day cream |
| CN103610616B (en) * | 2013-12-12 | 2015-06-10 | 孙晓晨 | Night cream containing soybean peptide and preparation method of night cream |
| CN104069015A (en) * | 2014-05-09 | 2014-10-01 | 广州大澳化妆品有限公司 | Eye cream containing plant extract |
| CN104739723A (en) * | 2015-03-19 | 2015-07-01 | 广东轻工职业技术学院 | Tightening eye cream |
| CN104922017A (en) * | 2015-06-09 | 2015-09-23 | 柳州弘天科技有限公司 | Day cream |
| CN104922016A (en) * | 2015-06-09 | 2015-09-23 | 柳州弘天科技有限公司 | Eye cream |
| CN104922018A (en) * | 2015-06-09 | 2015-09-23 | 柳州弘天科技有限公司 | Face cream |
| CN105943447A (en) * | 2016-06-17 | 2016-09-21 | 广州丹奇日用化工厂有限公司 | Vegetable protein peptide wrinkle reducing and resilience restoring eye cream |
| CN106726771A (en) * | 2016-12-28 | 2017-05-31 | 安徽檀鑫科技有限公司 | A kind of moisturizing anti-wrinkle eye cream and preparation method thereof |
| CN109157440A (en) * | 2018-11-09 | 2019-01-08 | 常州市蒽盗钟情生物科技有限公司 | A kind of preparation method of the wooden bloom of cream |
| CN109602655A (en) * | 2018-12-25 | 2019-04-12 | 广州葆妍生物科技有限公司 | It is a kind of with it is crease-resistant, remove black eye, the composition for going eye pouch effect and its preparation method and application |
| CN113827496A (en) * | 2021-09-25 | 2021-12-24 | 厦门传茗生物科技有限公司 | Multifunctional eye cream with special moisture effect and heavy oil feeling and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1152876A (en) * | 1994-05-17 | 1997-06-25 | 阿勒根 | Laerimal gland specific emulsions for topical application to ocular tissue |
| CN1237896A (en) * | 1996-12-12 | 1999-12-08 | 朗开斯特集团有限公司 | Cosmetic preparation with peptide addition |
| JP2004182718A (en) * | 2002-10-11 | 2004-07-02 | Kose Corp | Emulsion cosmetic of water-in-oil type |
| US20040191330A1 (en) * | 2003-03-31 | 2004-09-30 | Keefe Candace R. | Daily skin care regimen |
| JP2005068073A (en) * | 2003-08-25 | 2005-03-17 | Takashi Fukazawa | Cosmetic for skin around eye |
-
2005
- 2005-07-12 CN CNB200510046860XA patent/CN1319515C/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1152876A (en) * | 1994-05-17 | 1997-06-25 | 阿勒根 | Laerimal gland specific emulsions for topical application to ocular tissue |
| CN1237896A (en) * | 1996-12-12 | 1999-12-08 | 朗开斯特集团有限公司 | Cosmetic preparation with peptide addition |
| JP2004182718A (en) * | 2002-10-11 | 2004-07-02 | Kose Corp | Emulsion cosmetic of water-in-oil type |
| US20040191330A1 (en) * | 2003-03-31 | 2004-09-30 | Keefe Candace R. | Daily skin care regimen |
| JP2005068073A (en) * | 2003-08-25 | 2005-03-17 | Takashi Fukazawa | Cosmetic for skin around eye |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1723876A (en) | 2006-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1319515C (en) | Eye-cream for developing eye cytoactive | |
| US9381146B2 (en) | Skin conditioner | |
| CA2384080C (en) | Skin conditioner | |
| CA2323451A1 (en) | Skin conditioner | |
| US20090060850A1 (en) | Ericacea extracts for combating skin aging | |
| US10350156B2 (en) | Method for preparing cosmetic composition containing fermented ginseng berry Pleurotus ferulae product and use thereof | |
| CN106963706A (en) | A kind of eye-care compositions and medicine and eye-care product comprising said composition | |
| CN110115704B (en) | Enzyme composition and application thereof in cosmetics with whitening function | |
| WO2014191056A1 (en) | Combination of active agents for treating skin aging | |
| WO2024139786A1 (en) | Application of artemisia annua extract in preparation of anti-glycation product | |
| KR20140016461A (en) | Fermented sea cucumber extract and its cosmetic usage | |
| CN109431910A (en) | Skin barrier remediation composition and its application | |
| US11110117B2 (en) | Skin preparation composition for external use containing complex hyaluronic acid | |
| Seyger et al. | The efficacy of a new topical treatment for psoriasis: Mirak | |
| KR101585913B1 (en) | Method for production of horse leg bone extract and cosmetic composition with the extract of horse leg bone | |
| US20110178167A1 (en) | Method for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen using terminalia catappa leaf extract | |
| CN112274453B (en) | Skin-care matrix with whitening, anti-allergy and anti-aging functions and preparation method and application thereof | |
| CN104324367A (en) | Novel application of fish scale extract in preparation of medicine for treating and/or preventing leukoderma | |
| CN108186438A (en) | A kind of after-sun gel containing Porcine HGF and preparation method thereof | |
| KR101458496B1 (en) | A skin-care agent for anti-inflammatory containig Pleurotus ferulae fruit body extract or Pleurotus ferulae mycelium extract or Pleurotus ferulae mycelium culture fluid | |
| CN113730330A (en) | Eye cream composition with black eye removing effect and preparation method thereof | |
| CN108888573B (en) | Soothing and moisturizing cream and preparation method thereof | |
| CN104546629A (en) | Hydrating and whitening eye cream | |
| US9669064B2 (en) | Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or promoting expression of collagen using Ixora parviflora leaf extract | |
| CN118453459A (en) | Fermentation product extract and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHENYANG HO'S EYE INDUSTRIAL DEVELOPMENT CO., LTD Free format text: FORMER OWNER: SHENYANG HESHI BIOLOGY ENGINEERING CO., LTD. Effective date: 20080905 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20080905 Address after: No. 128 North Main Street, Huanggu District, Shenyang, Liaoning, the Yellow River Patentee after: Shenyang Silver Sea (3S) Eye Hospital Address before: Shenyang, Liaoning province moral and Economic Development Zone, two liang Road, Shen Shen West four street Patentee before: Shenyang Silver Sea (3S) Eye Hospital |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20210608 Address after: 110000 West 4th Street, Zhengliang 2nd Road, Shenyang Daoyi Economic Development Zone, Shenyang City, Liaoning Province Patentee after: Shenyang He's Biological Engineering Co.,Ltd. Address before: 110034 No. 128 North Main Street, Huanggu District, Liaoning, Shenyang, the Yellow River Patentee before: Shenyang He's Ophthalmic Industry Development Co.,Ltd. |
|
| TR01 | Transfer of patent right |